MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC)'s chief executive and co-founder Roby Zomer spoke to Proactive London about his company's exclusive distribution agreement.
It will introduce its propriety medicines, CannEpil and CogniCann, into markets in the UK and across Europe.
Zomer also spoke about the company shifting away from medical cannabis towards more of a 'pharmaceutical scheme.'